Your browser doesn't support javascript.
loading
Growth hormone control and cardiovascular function in patients with acromegaly.
Lin, Yi-Chun; Yu, Wen-Chung; Kuo, Chin-Sung; Chen, Harn-Shen.
Afiliação
  • Lin YC; Rong Yang Clinic, Taipei, Taiwan, ROC.
  • Yu WC; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.
  • Kuo CS; Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
  • Chen HS; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.
J Chin Med Assoc ; 84(2): 165-170, 2021 Feb 01.
Article em En | MEDLINE | ID: mdl-33055527
ABSTRACT

BACKGROUND:

Acromegaly is associated with cardiovascular alterations. Up to 50% acromegalic patients suffered from treatment failure after multiple modalities. We investigated correlation between cardiovascular function and control of growth hormone (GH) in acromegalic patients following transsphenoidal adenomectomy (TSA).

METHODS:

We recruited acromegalic patients who had undergone TSA between 2006 and 2014 in this cross-sectional study. Patients were assigned to group 1, controlled acromegaly (GH <1.0 ng/mL and normalized insulin-like growth factor-1 [IGF-1]); group 2, partially controlled acromegaly (either GH >1.0 ng/mL or non-normalized IGF-1); or group 3, uncontrolled acromegaly (GH >1.0 ng/mL and non-normalized IGF-1). Echocardiography evaluated the left ventricular mass index, left ventricular ejection fraction, and the early transmitral filling velocity (E)-to-late transmitral filling velocity (A) and the E-to-the early diastolic mitral annular velocity (E') ratios. Carotid tonometry evaluated the intima-media thickness of the carotid artery, carotid-femoral pulse wave velocity, augmentation index, aortic characteristic impedance (Zc), and pulse pressure amplification.

RESULTS:

Thirty-three patients participated in this study. Fourteen of the 33 patients were males (42%). Mean age at diagnosis was 50.33 years (SD 18.45). Compared to patients in group 1, patients in group 3 had younger age and shorter years after operation, without statistical significance. Cumulative GH levels were progressively higher from group 1 to group 3, without statistical significance. The groups did not differ with respect to cardiovascular structure and function evaluated by echocardiography and carotid tonometry. Only Zc value had a difference that was of borderline significance (group 1 109.13 ± 32.99; group 2 129.30 ± 32.27; group 3 159.56 ± 77.4 dynes × s/cm5; ANOVA p = 0.088; p = 0.086 for group 1 vs group 3).

CONCLUSION:

In the patients with acromegaly who had undergone TSA, cardiac structure and vascular stiffness did not differ among the groups with different levels of GH control.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acromegalia / Função Ventricular Esquerda / Hormônio do Crescimento Humano / Coração Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Chin Med Assoc Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acromegalia / Função Ventricular Esquerda / Hormônio do Crescimento Humano / Coração Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Chin Med Assoc Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article